Trichostatin A inhibits proliferation of PC3 prostate cancer cells by disrupting the EGFR pathway

Prostate cancer (PC) is the most common type of malignancy to exist in men within developed countries. Androgen deprivation therapy is performed for metastatic and advanced PC. However, the majority of cases of prostate cancer become refractory during therapy, leading to castration-resistant PC (CRP...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hong, Zhao, Xin, Liu, Hongbo, Jin, Hui, Ji, Youbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546995/
https://www.ncbi.nlm.nih.gov/pubmed/31289542
http://dx.doi.org/10.3892/ol.2019.10384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546995/
https://www.ncbi.nlm.nih.gov/pubmed/31289542
http://dx.doi.org/10.3892/ol.2019.10384

Ejemplares similares